Vandeven, N. (2018). Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationVandeven, N. Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationVandeven, N. Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.